Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1985
Endocrine factors in the treatment of prostatic cancer
C G Pierrepoint, A O Turkes, K J Walker, et al.
Mechanisms of Ageing and Development
|
June 21, 2005
The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals
M E Lemieux, X Yang, K Jardine, et al.
Science (New York, N.Y.)
|
August 8, 1986
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects
A G Fisher, L Ratner, H Mitsuya, et al.
Acta Endocrinologica
|
February 1, 1976
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy
M E Harper, W B Peeling, T Cowley, et al.
Cancer Research
|
November 1, 1981
Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate
H A Kemp, G F Read, D Riad-Fahmy, et al.
The Prostate
|
January 1, 1992
Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters
M E Harper, E Glynne-Jones, L Goddard, et al.
The Prostate
|
January 1, 1985
A prognostic index for the clinical management of patients with advanced prostatic cancer: a British Prostate Study Group investigation
D W Wilson, M E Harper, H M Jensen, et al.
The New England Journal of Medicine
|
October 23, 1986
Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease
M E Harper, M H Kaplan, L M Marselle, et al.
Oxford Reviews of Reproductive Biology
|
January 1, 1987
Cancer of the prostate: endocrine factors
K Griffiths, P Davies, C L Eaton, et al.
International Journal of Obesity (2005)
|
August 6, 2014
Low birth weight is associated with adiposity, impaired skeletal muscle energetics and weight loss resistance in mice
B Beauchamp, S Ghosh, M W Dysart, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
Progress in Clinical and Biological Research
|
January 1, 1985
Endocrine factors in the treatment of prostatic cancer
C G Pierrepoint, A O Turkes, K J Walker, et al.
Mechanisms of Ageing and Development
|
June 21, 2005
The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals
M E Lemieux, X Yang, K Jardine, et al.
Science (New York, N.Y.)
|
August 8, 1986
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects
A G Fisher, L Ratner, H Mitsuya, et al.
Acta Endocrinologica
|
February 1, 1976
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy
M E Harper, W B Peeling, T Cowley, et al.
Cancer Research
|
November 1, 1981
Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate
H A Kemp, G F Read, D Riad-Fahmy, et al.
The Prostate
|
January 1, 1992
Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters
M E Harper, E Glynne-Jones, L Goddard, et al.
The Prostate
|
January 1, 1985
A prognostic index for the clinical management of patients with advanced prostatic cancer: a British Prostate Study Group investigation
D W Wilson, M E Harper, H M Jensen, et al.
The New England Journal of Medicine
|
October 23, 1986
Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease
M E Harper, M H Kaplan, L M Marselle, et al.
Oxford Reviews of Reproductive Biology
|
January 1, 1987
Cancer of the prostate: endocrine factors
K Griffiths, P Davies, C L Eaton, et al.
International Journal of Obesity (2005)
|
August 6, 2014
Low birth weight is associated with adiposity, impaired skeletal muscle energetics and weight loss resistance in mice
B Beauchamp, S Ghosh, M W Dysart, et al.
Page
of 14